Cellyrix Therapeutics
PrivateLast Round
Seed
Dec 1, 2024
Company Overview
Cellyrix Therapeutics operates in Healthcare & Life Sciences and is based in Israel. Its latest recorded funding round was a Seed round in December 2024.
Cellyrix Therapeutics is a biotechnology company that leverages single-cell RNA sequencing and artificial intelligence to develop innovative cancer therapies targeting tumor heterogeneity.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cellyrix Therapeutics Comparables
Compare Cellyrix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QurieGen | 83% | |
| Phenomic AI | 80% | |
| One Biosciences | 78% |
For institutional investors. Book with your work email.
Cellyrix Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Cellyrix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Biotech Fund | Seed |
| Amiti Ventures | Seed |
| AION Labs | Seed |
Cellyrix Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cellyrix Therapeutics's valuation, stock price, and market status.
Is Cellyrix Therapeutics a public or private company?
Cellyrix Therapeutics is a private company.
What is the current stock price of Cellyrix Therapeutics?
Cellyrix Therapeutics is a private company, so its shares have no public market price. Caplight tracks Cellyrix Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cellyrix Therapeutics worth (valuation)?
Valuation information for Cellyrix Therapeutics is not publicly available.
Can I buy Cellyrix Therapeutics stock?
Cellyrix Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cellyrix Therapeutics's last funding round?
Cellyrix Therapeutics's most recent funding round was Seed on December 1, 2024.
Who are the main investors in Cellyrix Therapeutics?
Key investors in Cellyrix Therapeutics include AION Labs.
Will Cellyrix Therapeutics IPO soon?
No public IPO plans have been announced for Cellyrix Therapeutics.
How can I track Cellyrix Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Cellyrix Therapeutics's shares on secondary markets.